BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37168331)

  • 1. Identification of hub genes associated with head and neck squamous cell carcinoma by integrated bioinformatics approach and RNA-seq validation analysis.
    Shabeer A; Mustafa S; Bukhari RS; Abdel-Maksoud MA; Almutairi SM; Al-Qahtani WH; Chandio K; Khan NY; Gul J; Aufy M
    Am J Cancer Res; 2023; 13(4):1259-1277. PubMed ID: 37168331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The discovery of promising candidate biomarkers in kidney renal clear cell carcinoma: evidence from the in-depth analysis of high-throughput data.
    Li X; Li M; Zhao T; Zhang J
    Am J Cancer Res; 2023; 13(9):4288-4304. PubMed ID: 37818073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptomics data mining to uncover signature genes in head and neck squamous cell carcinoma: a bioinformatics analysis and RNA-sequencing based validation.
    Yu W; He X; Zhang C; Huangfu H
    Am J Cancer Res; 2023; 13(11):5513-5530. PubMed ID: 38058845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensively analyzing the genetic alterations, and identifying key genes in ovarian cancer.
    Tang Q; Atiq W; Mahnoor S; Abdel-Maksoud MA; Aufy M; Yaz H; Zhu J
    Oncol Res; 2023; 31(2):141-156. PubMed ID: 37304238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis reveals novel gene signature in head and neck squamous cell carcinoma: predicting is associated with poor prognosis in patients.
    Sun Y; Zhang Q; Yao L; Wang S; Zhang Z
    Transl Cancer Res; 2020 Oct; 9(10):5882-5892. PubMed ID: 35117201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of four signature genes for clinical testing through bioinformatics and in vitro methods in head and neck squamous cell carcinoma.
    Javed M; Bukhari RS; Rasool R; Alhomrani M; Alghamdi SA; Habeeballah H; Ramzan F; Baothman BK; Kashif M; Almaghrabi S; Izmirly AM; Khalid SY
    Am J Cancer Res; 2023; 13(5):1826-1844. PubMed ID: 37293145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of hub genes and exploration of multi-omics level alterations in the landscape of lung adenocarcinoma.
    Li G; Atiq W; Hashmi MF; Ibrahim SS; Al Abdulsalam KA; Kadham MJ; Al-Azzawi AKJ; Aufy M; Abdel-Maksoud MA
    Am J Transl Res; 2023; 15(3):1550-1568. PubMed ID: 37056815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering cervical cancer-associated biomarkers by integrated multi-omics approach.
    Li X; Abdel-Maksoud MA; Iqbal I; Mubarak A; Farrag MA; Haris M; Alghamdi S; Ain QU; Almekhlafi S
    Am J Transl Res; 2022; 14(12):8843-8861. PubMed ID: 36628250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of genetic mechanisms underlying lipid metabolism-mediated tumor immunity in head and neck squamous cell carcinoma.
    Liu S; Wang S; Wang Z
    BMC Med Genomics; 2023 May; 16(1):110. PubMed ID: 37210507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
    Sun K; Chen RX; Li JZ; Luo ZX
    Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated analysis of diagnostic, prognostic value and potential drug treatment of GSDME in head and neck squamous cell carcinoma.
    Hu R; Lu M; She L
    Eur Arch Otorhinolaryngol; 2023 Sep; 280(9):4239-4253. PubMed ID: 37204444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of ferroptosis driver gene signature in head and neck squamous cell carcinoma (HNSC).
    Shaikh K; Iqbal Y; Abdel-Maksoud MA; Murad A; Badar N; Alarjani KM; Siddiqui K; Chandio K; Almanaa TN; Jamil M; Ali M; Jabeen N; Hussein AM
    Am J Transl Res; 2023; 15(7):4829-4850. PubMed ID: 37560204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common gene signatures and key pathways in hypopharyngeal and esophageal squamous cell carcinoma: Evidence from bioinformatic analysis.
    Zhou R; Liu D; Zhu J; Zhang T
    Medicine (Baltimore); 2020 Oct; 99(42):e22434. PubMed ID: 33080677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods.
    Li Z; Lin Y; Cheng B; Zhang Q; Cai Y
    Front Genet; 2021; 12():571231. PubMed ID: 33767726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma.
    Gao W; Zhang ZW; Wang HY; Li XD; Peng WT; Guan HY; Liao YX; Liu A
    Front Genet; 2022; 13():895281. PubMed ID: 35754792
    [No Abstract]   [Full Text] [Related]  

  • 16. Constructing a prognostic model for head and neck squamous cell carcinoma based on glucose metabolism related genes.
    Liu Y; Liu N; Zhou X; Zhao L; Wei W; Hu J; Luo Z
    Front Endocrinol (Lausanne); 2023; 14():1245629. PubMed ID: 37876534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Hub Genes as Potential Prognostic Biomarkers in Cervical Cancer Using Comprehensive Bioinformatics Analysis and Validation Studies.
    Xue H; Sun Z; Wu W; Du D; Liao S
    Cancer Manag Res; 2021; 13():117-131. PubMed ID: 33447084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative Bioinformatics Analysis Identifies NEK2 as a Potential Biomarker in Head and Neck Squamous Cell Carcinoma.
    Liu S; Tian W; Li B
    J Comput Biol; 2020 Jan; 27(1):100-108. PubMed ID: 31460782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering key genes involved in cisplatin resistance in kidney renal clear cell carcinoma through a combined
    Malik M; Maqbool M; Nisar T; Akhter T; Ujan JA; Algarni AS; Joufi FAA; Alanazi SSK; Almotared MH; Bekhit MMS; Jamil M
    Oncol Res; 2023; 31(6):899-916. PubMed ID: 37744271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genes regulating sensitivity of tumor cells to T cell-mediated killing: could they be potential personalized immunotherapeutic targets in head and neck squamous cell carcinoma?
    Hu S; Duan H; Lu Y; Huang S
    Discov Oncol; 2023 Nov; 14(1):199. PubMed ID: 37926766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.